Disc Medicine Reports Q3 GAAP EPS of -$1.53, Exceeding Analyst Expectations
Disc Medicine (IRON) reported third-quarter GAAP earnings per share of -$1.53, surpassing market expectations by $0.20. Despite the net loss, the company demonstrated a robust liquidity position, ending the quarter with approximately $683 million in cash, cash equivalents, and marketable securities. The company further strengthened its balance sheet through a public offering completed in October, which generated net proceeds of roughly $486 million. This capital infusion is intended to extend the company's operational cash runway as it continues its clinical development programs.
Tickers: $IRON
Topics: cash runway earnings beat public offering